AbbVie Inc. (ABBV) vs Advanced Micro Devices, Inc. (AMD)

See how AbbVie Inc. and Advanced Micro Devices, Inc. differ across market data and performance, so you can decide which asset best fits your strategy.

$285.42
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page
$528.75
NasdaqGS
Advanced Micro Devices develops a broad range of digital semiconductors for end markets including PCs, gaming consoles, data centers with AI workloads, industrial systems, and automotive applications. The company has traditionally been strongest in central processing units and graphics processing units for PCs and data centers, while increasingly establishing itself as a notable competitor in AI GPUs and related hardware. AMD also provides the chips used in leading game consoles such as Sony PlayStation and Microsoft Xbox.
View Full Page

Key Metrics Comparison

AbbVie Inc.ABBV
Market Cap
$504.371B
Price
$285.42
24h Change
+0.71%
24h Volume
$5.64M
Employees
57,000
Shares Outstanding
1,768,169,012
Advanced Micro Devices, Inc.AMD
Market Cap
$863.171B
Price
$528.75
24h Change
-5.95%
24h Volume
$22.4M
Employees
31,000
Shares Outstanding
1,630,338,779

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
ABBV
36.9%
AMD
63.1%

Volume Share

Share of combined 24h volume

Volume Share
ABBV
20.1%
AMD
79.9%

24h Performance

Price change over last 24 hours

24h Performance
ABBV
0.71%
AMD
-5.95%
Price Comparison
AbbVie Inc.
Advanced Micro Devices, Inc.